NovaBay Pharmaceuticals to Hold Third Quarter 2018 Conference Call on November 14, 2018

NovaBay Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova for the domestic eye care market, announces that it will report third quarter 2018 financial results after market close on Wednesday, November 14. Management will hold an investment community conference call that day to discuss financial results and provide a Company update.

DATE:       Wednesday, November 14
TIME: 4:30 p.m. ET / 1:30 p.m. PT
DIAL IN: 800-608-8202 from within the U.S.
702-495-1913 from outside the U.S.
Enter conference identification number 5709629

The live call also will be available at A replay of the call will be available beginning two hours after its completion through 11:59 p.m. Eastern time November 20, 2018, by dialing 855-859-2056 from within the U.S. or 404-537-3406 from outside the U.S. and entering the conference identification number 5709620. The call will also be archived at

About NovaBay Pharmaceuticals, Inc.: Going Beyond Antibiotics

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focused on commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global, topical anti-infective market with its two distinct product categories: the NEUTROX family of products and the AGANOCIDE compounds. The Neutrox family of products includes AVENOVA for the eye care market, NEUTROPHASE for the wound care market and CELLERX for the aesthetic dermatology market. The Aganocide compounds, still under development, have target applications in dermatology and urology.

Socialize and Stay informed on NovaBays progress: Like us on Facebook Follow us on Twitter Connect with NovaBay on LinkedIn Join us on Google+ Visit NovaBays Website


Subscribe to the Global Banking & Finance Review Newsletter for FREE
Get Access to Exclusive Reports to Save Time & Money

By using this form you agree with the storage and handling of your data by this website. We Will Not Spam, Rent, or Sell Your Information.
All emails include an unsubscribe link. You may opt-out at any time. See our privacy policy.

NovaBay Contacts For NovaBay Avenova purchasing information: Please Call us toll free: 1-800-890-0329 or email [email protected].

NovaBay Pharmaceuticals, Inc.
Jack McGovern, 510-899-8800
Executive Officer and
Chief Financial Officer
[email protected]

LHA Investor Relations
Jody Cain, 310-691-7100
[email protected]